Search

everythinglearnresearchcommunity

for

Search:↓

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

Trichorrhexis nodosa is mainly caused by hair trauma, not a metabolic defect.

Matriptase imbalance contributes to cancer development and spread.

Combining FTSC with TSN6 peptide greatly improves wound healing.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

αCT1 improves scar appearance by changing early collagen structure.

The combination treatment showed a higher response rate but no significant survival benefits.

Using DNase enzymes to break down harmful NETs could be a new treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

A child with ectodermal dysplasia-syndactyly syndrome has a new mutation in the NECTIN4 gene.

The patch speeds up wound healing by using electricity and heat.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Avoiding damage and using specific shampoo and supplements improved the hair condition.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Tenascin is present in normal skin and certain skin tumors but not in sebaceous glands or their tumors.

TSN6 peptide improves skin thickness and hair growth.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Matriptase is crucial for keeping epithelial tissues healthy and functioning properly.

A woman's severe skin reaction was caused by an allergy to a skin treatment.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Tofacitinib might be used to treat hair loss.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.